Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-022294

Chief Executive Officer acquired 23,370 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2024-08-15 Grant or award +19,272 460,071 D: show line 1 in the form
Farrell Michael J. Chief Executive Officer 2024-08-15 Grant or award +4,098 464,169 D: show line 2 in the form
Loading xslF345X05/form4.xml…